Goldman Sachs gets it đź‘Ť Started coverage on
$VEEV, the leader in cloud-based software for the global life sciences industry. Price target of $253, which is roughly my valuation, too. Can’t believe the company hasn’t been added to the S&P 500 yet, just a matter of time.